Market Overview

UPDATE: JP Morgan Initiates IMAX Corporation with Overweight, $30 PT on Growth Outlook

Share:
Related IMAX
Credit Suisse's Tech, Media And Telecom Conference: Here's A List Of The Top Presenters
Weekend Box Office Misses Target Despite Solid 'Fantastic Beasts' Open

JP Morgan initiates its coverage on IMAX Corporation (NYSE: IMAX) with a rating of Overweight and a price target of $30.

JP Morgan notes, "We are initiating coverage of IMAX with an Overweight rating and $30 Dec 2012 price target. We find shares attractive for a high visibility, long-term growth story that is one of the few plays on emerging market box office growth. IMAX also benefits from a unique business model within the industry that delivers high profitability and recurring FCF generation with every screen added to its network. The company has established itself as a valuable brand to both consumers and filmmakers, which we expect will help maintain its advantaged position in the global theatrical industry."

IMAX closed at $24.03 on Friday.

Latest Ratings for IMAX

DateFirmActionFromTo
Nov 2016Credit SuisseAssumesOutperform
Sep 2016MacquarieMaintainsOutperform
Jul 2016Roth CapitalAssumesBuy

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Initiation Intraday Update Analyst Ratings

 

Related Articles (IMAX)

View Comments and Join the Discussion!